¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ascorbic Acid type SC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • lichenic acid
    ÁöÀÇ»ê
  • linoleic acid
    ¸®³î·¹»ê
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • lactic acid
    Á¥»ê
  • mixed acid
    È¥ÇÕ»ê
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • malic acid
    ¸»»ê
  • malonic acid
    ¸»·Ð»ê
  • mixed acid
    È¥ÇÕ»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ³ªÀÌÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    Áú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acid, muramic
    ¹Â¶ó¹Í»ê
  • acid, teichoic
    ŸÀÌÄÚ»ê
  • acid, teichuronic
    ŸÀÌÅ¥·Ð»ê
  • acid, ¥â-hydroxymyristic
    º£Å¸ÇÏÀ̵å·Ï½Ã¹Ì¸®½ºÆ¾»ê
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
  • acid-fast stain
    Ç׻꼺 ¿°»ö
  • acid-fast stain
    Ç׻꼺¿°»ö(ù÷ß«àõæøßä)
  • acid<³ª> acidus
    »ê(ß«), »ê¼º(ß«àõ)ÀÇ.
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ëÈ¿¼Ò.
  • aliphatic acid
    Áö¹æÁ·»ê(ò·Û¸ðéß«).
  • aliphatic amino acid
    Áö¹æÁ·¾Æ¹Ì³ë»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • sickle cell type
    °â»óÀûÇ÷±¸Çü
  • sinus venosus type
    Á¤¸Æµ¿Çü.
  • sinus venosus type
    Á¤¸Æµ¿Çü(¡­Ô×Çü)
  • skeleton type denture
    °ñ°ÝÈ­ÀÇÄ¡»ó(ÍéÌ«ûùëùöÍßÉ).
  • somatic type
    ½ÅüÇü
  • spaced type of deciduous dentition
    À¯±ØÇü À¯Ä¡¿­±Ã(êóÐÀû¡êáöÍæêÏá).
  • specific type
    ÇüƯÀ̼º(úþ÷åì¶àõ)
  • spectral type
    ½ºÆåÆ®·³Çü(¡­úþ).
  • spinal type
    ô¼öÇü(ô±âÐúþ).
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • split-electrode-type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ (ÝÂùÜ ï³Ð¿ ÷®õºí­)
  • sthenic type
    ±Ù·ÂÇü(ÐÉæ³úþ).
  • storage-type
    ÃàÀûÇü
  • supporting cell [type ii glomus cell]
    ¹öÆÀ¼¼Æ÷
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü(äâìÔû¡ ÐÝή).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • ethylenediaminetetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)¾Æ¹Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • ethylenedinitrolotetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)³ªÀÌÆ®·Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • even-numbered fatty acid
    ¦¼ö Áö¹æ»ê(ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid activating enzyme
    Áö¹æ»ê Ȱ¼ºÈ­ È¿¼Ò (ò·Û¸ß«üÀàõûùý£áÈ)
  • fatty acid activation
    Áö¹æ»ê Ȱ¼ºÈ­ (ò·Û¸ß«üÀàõûù)
  • fatty acid CoA ligase
    Áö¹æ»ê(ò·Û¸ß«) CoA ¶óÀ̰ÔÀ̽º
  • fatty acid oxidation
    Áö¹æ»ê »êÈ­ (ò·Û¸ß«ß«ûù)
  • fatty acid synthetase system
    Áö¹æ»ê ÇÕ¼º È¿¼Ò(ò·Û¸ß«ùêà÷ý£áÈ)½Ã½ºÅÛ
  • fatty acid thiokinase
    Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • folic acid
    Æú»ê(ß«)
  • folic acid coenzyme
    Æú»ê(ß«) º¸È¿¼Ò(ÜÍý£áÈ)
  • folic acid conjugate
    Æú»ê(ß«) Æ÷ÇÕü(øÙùêô÷)
  • folic acid reductase
    Æú»ê(ß«) ¸®´ÚÅ×À̽º
  • folinic acid
    Æú¸°»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
KA alkaline phosphatase; kainic acid; keratoacanthoma; keto acid; ketoacidosis; King-Armstrong [unit]
LA lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left...
LAD lactic acid dehydrogenase; left anterior descending [artery]; left axis deviation; leukocyte adhesio...
MA malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
APS-1 Autoimmune polyglandular syndrome type 1
B-CLL B cell Type
B-CLL B type chronic lymphocytic leukaemia
BNP B type natriuretic peptide
BOTOX Botulinum Toxin Type A
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • essential amino acid
    Çʼö ¾Æ¹Ì³ë»ê
    ´Ü¹éÁúÀÇ ±âº» ±¸¼º ´ÜÀ§. ´Ü¹éÁúÀº ü³»¿¡¼­ ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØµÇ°í ³ª¼­ Èí¼ö, ÀÌ¿ëµÈ´Ù. µû¶ó¼­ ´Ü¹éÁúÀÇ ¿µ¾ç°¡´Â ±× ¼Ó¿¡ ÇÔÀ¯µÇ´Â ¾Æ¹Ì³ë»êÀÇ Á¾·ù¿Í ¾ç¿¡ ÀÇÇÏ¿© Á¤ÇØÁø´Ù. ¾Æ¹Ì³ë»êÀº µ¿¹°ÀÇ Ã¼³»¿¡¼­ ´Ù¸¥ ¾Æ¹Ì³ë»êÀ¸·ÎºÎÅÍ ¸¸µé¾îÁö´Â °Í°ú, ü³»¿¡¼­´Â ÇÕ¼ºµÇÁö ¾Ê°í À½½ÄÀ¸·Î ¼·ÃëµÇ¾î¾ß ÇÏ´Â °ÍÀÌ ÀÖ´Ù. µû¶ó¼­ ¼·ÃëÇÏÁö ¾ÊÀ¸¸é ¿ÏÀüÇÑ ´Ü¹éÁúÀÌ µÇÁö ¾Ê´Â´Ù. ÀÌ·¸°Ô ü³»¿¡¼­ ÇÕ¼ºÇÒ ¼ö ¾ø´Â ¾Æ¹Ì³ë»êÀ» Çʼö ¾Æ¹Ì³ë»ê ¶Ç´Â ºÒ°¡°á ¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. Çʼö ¾Æ¹Ì³ë»êÀÇ Á¾·ù´Â µ¿¹°ÀÇ Á¾·ù³ª ¼ºÀå ½Ã±â¿¡ µû¶ó ´Ù¸£Áö¸¸, ¼ºÀÎÀÇ °æ¿ì¿¡´Â ´ÙÀ½ÀÇ 8Á¾ÀÌ´Ù. À̼ҷù½Å, ·ù½Å, ¸®½Å, Æä´Ò¾Ë¶ó´Ñ, ¸ÞƼ¿À´Ñ, Æ®·¹¿À´Ñ, Æ®¸³ÅäÆÇ, ¹ß¸°ÀÌ´Ù. ¾î¸°¾ÆÀÌÀÇ °æ¿ì¿¡´Â ¿©±â¿¡ È÷½ºÆ¼µòÀÌ ´õÇØÁø´Ù.
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • ethacrynic acid
    ¿¡Å¸Å©¸°»ê
  • ethylene-diamin tetra-acetic acid
    ¿¡Æ¿·»µð¾Æ¹Î »ç-¾Æ¼¼Æ®»ê
    ¹é»öÀÇ ºÐ¸»·Î Á߱ݼÓ. ¾ËÄ®¸®Åä ±Ý¼Ó µî°ú È­ÇÕÇÏ¿© Àß ³ì´Â ¸Å¿ì ¾ÈÁ¤µÈ Ű·¹ÀÌÆ® È­ÇÕ¹°À» ¸¸µé°í, ¹æ»ç¼º ¿ø¼ÒÀÇ Å»¿À¿°. ¹°ÀÇ °æµµ ºñ»ö ºÐ¼®. ±Ý¼ÓÀÇ ¿ë·® ºÐ¼® µî¿¡ »ç¿ëµÇ¸ç, ÃÖ±Ù¿¡´Â Ç÷¾×À» ÀúÀåÇϴµ¥ ÷»çÇϸé Ç×ÀÀ°í¼º°ú º¸Á¸ ±â°£ÀÇ ¿¬ÀåÀ» °¡´ÉÄÉ ÇÑ´Ù´Â °ÍÀÌ ÆÇ¸íµÇ¾ú´Ù.
  • fatty acid cyclooxygenase
    Áö¹æ»ê »çÀÌŬ·Î¿Á½ÃÁö³×À̽º
  • folic acid antagonist
    ¿±»ê ±æÇ×Á¦
  • folic acid deficiency anemia
    ¿±»ê °áÆð¼º ºóÇ÷
  • formic acid
    Æ÷¸§»ê, °³¹Ì»ê, ÀÇ»ê
  • formiminoglutamic acid
    Æ÷¸£¹Ì¹Ì³ë±Û·çŸ¹Í »ê
    ±Û·çŸ¹Î»êÀÌ È÷½ºÆ¼Æ¾À¸·Î ºÐÇØµÇ´Â °ú Á¤ÀÇ Áß°£ »ê¹°ÀÌ´Ù.
  • free acid
    À¯¸® »ê
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • fumaric acid
    Ǫ¸¶¸£ »ê
    ºÒÆ÷È­ ÀÌ¿°±â»ê. Æ®¶óÀÌ Ä«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£Ã¼.
  • humic acid
    È޹λê
  • humus acid
    ºÎ½Ä »ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
    ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëµÇ´Â »ê ¿ë¾×.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
type I acrocephalosyndactyly <paediatrics> A usually inherited disorder characterised by premature closing of the cranial suture lines resulting in a peaked shaped head and abnormal facial appearance.
Since it is usually autosomal dominant one or both parents also have the disorder. Surgery is used to correct skull and facial abnormalities.
Inheritance: autosomal dominant.
(29 Dec 1997)
type I cells Highly attentuated squamous cell's that form the gas-permeable epithelium lining the alveoli of the lungs.
Synonym: type I cells.
(05 Mar 2000)
type I collagen The most abundant collagen, which forms large well-organised fibrils having high tensile strength.
(05 Mar 2000)
type I diabetes A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes.
(09 Oct 1997)
type I diabetes mellitus <endocrinology> A severe metabolic disorder which has an abrupt onset before the age of twenty. In it, an insulin deficiency prevents the body from using carbohydrates properly and forces it to rely mainly on protein metabolism.
Treatment of the disease includes strict dietary regulation and mandatory insulin injections.
(09 Oct 1997)
type I dip Early deceleration of the foetal heart rate at the height of uterine contraction, as displayed on a foetal monitor graph.
(05 Mar 2000)
type i error The statistical error (said to be of the first kind or alpha error) made in testing an hypothesis when it is concluded that a treatment or intervention is effective when it really is not. Sometimes referred to as a false positive.
(12 Dec 1998)
type I familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by the presence of large amounts of chylomicrons and triglycerides in the plasma when the patient has a normal diet, and their disappearance on a fat-free diet; low alpha-and beta-lipoproteins on a normal diet, with increase on fat-free diet; decreased plasma postheparin lipolytic activity; and low tissue lipoprotein lipase activity. It is accompanied by bouts of abdominal pain, hepatosplenomegaly, pancreatitis, and eruptive xanthomas; autosomal recessive inheritance.
See: familial lipoprotein lipase inhibitor.
Synonym: Burger-Grutz syndrome, familial fat-induced hyperlipaemia, familial hyperchylomicronaemia, familial hypertriglyceridemia, idiopathic hyperlipaemia.
(05 Mar 2000)
type IH mucopolysaccharidosis <syndrome> Mucopolysaccharidosis in which there is a deficiency of alpha-l-iduronidase, an accumulation of an abnormal intracellular material, and excretion of dermatan sulfate and heparan sulfate in the urine; with severe abnormality in development of skeletal cartilage and bone, with dwarfism, kyphosis, deformed limbs, limitation of joint motion, spadelike hand, corneal clouding, hepatosplenomegaly, mental retardation, and gargoyle-like facies; autosomal recessive inheritance.
See: mucolipidosis.
Synonym: dysostosis multiplex, Hurler's disease, lipochondrodystrophy, Pfaundler-Hurler syndrome, type IH mucopolysaccharidosis.
(05 Mar 2000)
type I H/S mucopolysaccharidosis <syndrome> Although clinically distinct diseases, fibroblasts from patients with Hurler syndrome and with Scheie syndrome do not cross complement in culture, suggesting that the enzyme defect is the same.
(18 Nov 1997)
type I hyperlipoproteinaemia <biochemistry> An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood.
Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas).
Origin: Gr. Haima = blood
(27 Sep 1997)
type II acrocephalosyndactyly type II acrocephalosyndactyly
type II cells Cuboidal cell's connected with the squamous pulmonary alveolar cell's and having in their cytoplasm lamellated bodies (cytosomes) that represent the source of the surfactant that coats the alveoli.
Synonym: granular pneumonocytes, type II cells.
(05 Mar 2000)
type II collagen Collagen unique to cartilage, nucleus pulposis, notochord, and vitreous body; it forms as thin highly glycosylated fibrils.
(05 Mar 2000)
type II diabetes <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á